Differential stem-and progenitor-cell trafficking by prostaglandin e 2

Nature

Volumn 495, Issue 7441, 2013, Pages 365-369

  Hoggatt, Jonathan ^a,b   Mohammad, Khalid S ^a   Singh, Pratibha ^a   Hoggatt, Amber F ^a,c   Chitteti, Brahmananda R ^a   Speth, Jennifer M ^a   Hu, Peirong ^a   Poteat, Bradley A ^a   Stilger, Kayla N ^a   Ferraro, Francesca ^b   Silberstein, Lev ^b   Wong, Frankie K ^b   Farag, Sherif S ^a   Czader, Magdalena ^a   Milne, Ginger L ^d   Breyer, Richard M ^d   Serezani, Carlos H ^a   Scadden, David T ^b   Guise, Theresa A ^a   Srour, Edward F ^a   Pelus, Louis M ^a   more..

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOPONTIN; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E2;

BIOCHEMISTRY; BLOOD; CYTOLOGY; DISEASE TREATMENT; DRUG; FUNCTIONAL ROLE; GENOMICS; HOMEOSTASIS; INHIBITION; MAMMAL; PHYSIOLOGY; PROTEIN; RODENT; SIGNALING;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL EXPANSION; CELL MIGRATION; ENGRAFTMENT; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL MOBILIZATION; STEM CELL NICHE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL COUNT; CELL MOVEMENT; CELLS, CULTURED; DINOPROSTONE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOPONTIN; PAPIO; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; STEM CELLS; THIAZINES; THIAZOLES;

MAMMALIA; MUS; PRIMATES;

EID: 84875368879     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11929     Document Type: Article

References (40)

1. Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841-846 (2003).
2. Ding, L., Saunders, T. L.,Enikolopov, G.&Morrison,S. J.Endothelial andperivascular cells maintain haematopoietic stem cells. Nature 481, 457-462 (2012).
3. Méndez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834 (2010).
4. Raaijmakers, M. H. et al. Bone progenitor dysfunction inducesmyelodysplasia and secondary leukaemia. Nature 464, 852-857 (2010).
5. Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836-841 (2003).
6. Hoggatt, J., Singh, P., Sampath, J.&Pelus, L. M. Prostaglandin E2 enhances hematopoietic stemcellhoming, survival, and proliferation. Blood113,5444-5455(2009).
7. North, T. E. et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447, 1007-1011 (2007).
8. Ahmed, M.,Khanna, D.&Furst, D. E.Meloxicamin rheumatoidarthritis. ExpertOpin. Drug Metab. Toxicol. 1, 739-751 (2005).
9. Rinder, H. M. et al. Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial. J. Clin. Pharmacol. 42, 881-886 (2002).
10. Breyer, R. M., Bagdassarian, C. K., Myers, S. A.&Breyer, M. D. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41, 661-690 (2001).
11. Katayama, Y. et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407-421 (2006).
12. Bethel, M., Srour, E. F. & Kacena, M. A. Hematopoietic cell regulation of osteoblast proliferation and differentiation. Curr. Osteoporos. Rep. 9, 96-102 (2011).
13. Hoggatt, J.&Pelus, L. M.Manymechanismsmediatingmobilization: an alliterative review. Curr. Opin. Hematol. 18, 231-238 (2011).
14. Mundy, G. R., Yoneda, T. & Hiraga, T. Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment. Semin. Oncol. 28, 35-44 (2001).
15. Winkler, I. G. et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116, 4815-4828 (2010).
16. Chow, A. et al. Bone marrow CD1691 macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261-271 (2011).
17. Christopher, M. J., Rao, M., Liu, F., Woloszynek, J. R. & Link, D. C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208, 251-260 (2011).
18. Heissig, B. et al. Recruitment of stem and progenitor cells from the bone marrow niche requiresMMP-9 mediated release of Kit-ligand. Cell 109, 625-637 (2002).
19. Chitteti, B. R. et al. Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function. Blood 115, 3239-3248 (2010).
20. Nakamura, Y. et al. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood 116, 1422-1432 (2010).
21. Stier, S. et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781-1791 (2005).
22. Grassinger, J. et al. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with a9b1 and a4b1 integrins. Blood 114, 49-59 (2009).
23. Nie, Y. et al. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J. Exp. Med. 200, 1145-1156 (2004).
24. Kennedy, C. R. et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nature Med. 5, 217-220 (1999).
25. Guan, Y. et al. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J. Clin. Invest. 117, 2496-2505 (2007).
26. Schneider, A. et al. Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 40, 7-14 (2004).
27. Mignone, J. L., Kukekov, V., Chiang, A. S., Steindler, D. & Enikolopov, G. Neural stem andprogenitor cells in nestin-GFPtransgenic mice. J.Comp.Neurol.469,311-324 (2004).
28. Kalajzic, Z. et al. Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone 31, 654-660 (2002).
29. Chen, X. S., Sheller, J. R., Johnson, E. N. & Funk, C. D. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372, 179-182 (1994).
30. King, A. G. et al. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GROb. Blood 97, 1534-1542 (2001).
31. Pelus, L. M., Broxmeyer, H. E., Kurland, J. I. & Moore, M. A. Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J. Exp. Med. 150, 277-292 (1979).
32. Broxmeyer, H. E. et al. SDF-1/CXCL12 enhances in vitro replating capacity of murine and human multipotential and macrophage progenitor cells. Stem Cells Dev. 16, 589-596 (2007).
33. Fukuda, S., Bian, H., King, A. G. & Pelus, L. M. The chemokine GROb mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 110, 860-869 (2007).
34. Hoggatt, A. F., Hoggatt, J., Honerlaw, M. & Pelus, L. M. A spoonful of sugar helps the medicine go down: a novel technique to improve oral gavage in mice. J. Am. Assoc. Lab. Anim. Sci. 49, 329-334 (2010).
35. Sutherland, D. R., Anderson, L., Keeney, M., Nayar, R. & Chin-Yee, I. The ISHAGE guidelines for CD341 cell determination by flow cytometry. J. Hematother. 5, 213-226 (1996).
36. Mohammad, K. S. et al. Pharmacologic inhibition of the TGF-b type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS ONE 4, e5275 (2009).
37. Rowe, P. S. et al. Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin. Bone 39, 773-786 (2006).
38. Parfitt, A. M. et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610 (1987).
39. Murali, G. et al. Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR2/2 mice. J. Lipid Res. 53, 2186-2197 (2012).
40. Liu, T. et al. Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation. Proc. Natl Acad. Sci. USA 109, 12692-12697 (2012).